Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Schistosomiasis in European Travelers and Migrants: Analysis of 14 Years TropNet Surveillance Data.

Lingscheid T, Kurth F, Clerinx J, Marocco S, Trevino B, Schunk M, Muñoz J, Gjørup IE, Jelinek T, Develoux M, Fry G, Jänisch T, Schmid ML, Bouchaud O, Puente S, Zammarchi L, Mørch K, Björkman A, Siikamäki H, Neumayr A, Nielsen H, Hellgren U, Paul M, Calleri G, Kosina P, Myrvang B, Ramos JM, Just-Nübling G, Beltrame A, Saraiva da Cunha J, Kern P, Rochat L, Stich A, Pongratz P, Grobusch MP, Suttorp N, Witzenrath M, Hatz C, Zoller T; TropNet Schistosomiasis Investigator Group.

Am J Trop Med Hyg. 2017 Aug;97(2):567-574. doi: 10.4269/ajtmh.17-0034. Epub 2017 Jul 19.

2.

Severe malaria in Europe: an 8-year multi-centre observational study.

Kurth F, Develoux M, Mechain M, Malvy D, Clerinx J, Antinori S, Gjørup IE, Gascon J, Mørch K, Nicastri E, Ramharter M, Bartoloni A, Visser L, Rolling T, Zanger P, Calleri G, Salas-Coronas J, Nielsen H, Just-Nübling G, Neumayr A, Hachfeld A, Schmid ML, Antonini P, Lingscheid T, Kern P, Kapaun A, da Cunha JS, Pongratz P, Soriano-Arandes A, Schunk M, Suttorp N, Hatz C, Zoller T.

Malar J. 2017 Jan 31;16(1):57. doi: 10.1186/s12936-016-1673-z.

3.

Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria.

Kurth F, Lingscheid T, Steiner F, Stegemann MS, Bélard S, Menner N, Pongratz P, Kim J, von Bernuth H, Mayer B, Damm G, Seehofer D, Salama A, Suttorp N, Zoller T.

Emerg Infect Dis. 2016 Aug;22(8):1381-6. doi: 10.3201/eid2208.151905.

4.

A diagnostic predicament: activated sarcoidosis or pulmonary histoplasmosis. A case report.

Lingscheid T, von Heinz M, Klages B, Rickerts V, Tintelnot K, Gerhold M, Oestmann JW, Becker M, Temmesfeld-Wollbrück B, Suttorp N, Hübner RH.

Clin Respir J. 2017 May;11(3):374-377. doi: 10.1111/crj.12344. Epub 2015 Jul 23.

PMID:
26152858
5.

Azithromycin inhibits IL-1 secretion and non-canonical inflammasome activation.

Gualdoni GA, Lingscheid T, Schmetterer KG, Hennig A, Steinberger P, Zlabinger GJ.

Sci Rep. 2015 Jul 8;5:12016. doi: 10.1038/srep12016.

6.

In vitro activity of immunosuppressive drugs against Plasmodium falciparum.

Veletzky L, Rehman K, Lingscheid T, Poeppl W, Loetsch F, Burgmann H, Ramharter M.

Malar J. 2014 Dec 4;13:476. doi: 10.1186/1475-2875-13-476.

7.

Daptomycin plus fosfomycin, a synergistic combination in experimental implant-associated osteomyelitis due to methicillin-resistant Staphylococcus aureus in rats.

Lingscheid T, Poeppl W, Bernitzky D, Veletzky L, Kussmann M, Plasenzotti R, Burgmann H.

Antimicrob Agents Chemother. 2015 Feb;59(2):859-63. doi: 10.1128/AAC.04246-14. Epub 2014 Nov 17.

8.

Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats.

Poeppl W, Lingscheid T, Bernitzky D, Schwarze UY, Donath O, Perkmann T, Kozakowski N, Plasenzotti R, Reznicek G, Burgmann H.

Antimicrob Agents Chemother. 2014 Sep;58(9):5111-6. doi: 10.1128/AAC.02720-13. Epub 2014 Jun 16.

9.

Assessing pharmacokinetics of different doses of fosfomycin in laboratory rats enables adequate exposure for pharmacodynamic models.

Poeppl W, Lingscheid T, Bernitzky D, Donath O, Reznicek G, Zeitlinger M, Burgmann H.

Pharmacology. 2014;93(1-2):65-8. doi: 10.1159/000357569. Epub 2014 Feb 5.

PMID:
24503567
10.

In vitro activity of doripenem plus fosfomycin against drug-resistant clinical blood isolates.

Lingscheid T, Tobudic S, Poeppl W, Mitteregger D, Burgmann H.

Pharmacology. 2013;91(3-4):214-8. doi: 10.1159/000348572. Epub 2013 Mar 28.

PMID:
23548688
11.

Low nasal carriage of drug-resistant bacteria among medical students in Vienna.

Gualdoni GA, Lingscheid T, Tobudic S, Burgmann H.

GMS Krankenhhyg Interdiszip. 2012;7(1):Doc04. doi: 10.3205/dgkh000188. Epub 2012 Apr 4.

12.

Daptomycin, fosfomycin, or both for treatment of methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model.

Poeppl W, Tobudic S, Lingscheid T, Plasenzotti R, Kozakowski N, Lagler H, Georgopoulos A, Burgmann H.

Antimicrob Agents Chemother. 2011 Nov;55(11):4999-5003. doi: 10.1128/AAC.00584-11. Epub 2011 Aug 22.

13.

Efficacy of fosfomycin in experimental osteomyelitis due to methicillin-resistant Staphylococcus aureus.

Poeppl W, Tobudic S, Lingscheid T, Plasenzotti R, Kozakowski N, Georgopoulos A, Burgmann H.

Antimicrob Agents Chemother. 2011 Feb;55(2):931-3. doi: 10.1128/AAC.00881-10. Epub 2010 Nov 22.

Supplemental Content

Loading ...
Support Center